Introduction {#s1}
============

*Rhodococcus equi* is a gram-positive, facultative, intracellular pathogen that primarily infects macrophages [@pone.0062879-Meijer1]. Although recognized as a cause of disease in people, particularly those that are immunocompromised by HIV or chemotherapeutics, *R. equi* is most commonly recognized as a cause of severe pneumonia in the equine species [@pone.0062879-Muscatello1]--[@pone.0062879-Takai1]. Among horses, the disease occurs almost exclusively among foals, predominately during the first 3 months of life; mature horses are rarely affected unless they have an underlying immunodeficiency [@pone.0062879-Giguere1], [@pone.0062879-Giguere2]. The finding that *R. equi* pneumonia is essentially restricted to foals is likely related to exposure and infection during early life and naïve or diminished immune responses of neonatal foals. Although the age at which foals develop *R. equi* pneumonia remains unknown, epidemiological and clinical evidence indicate that foals are likely infected very early in life [@pone.0062879-Chaffin1], [@pone.0062879-Horowitz1]. This evidence is consistent with the insidious development of clinical signs in most affected foals [@pone.0062879-Giguere1], and the time required for development of large, pyogranulomatous lesions caused by *R. equi*. Evidence exists that the systemic immune system of newborn foals is diminished relative to more mature foals and horses, including both innate and adaptive responses to *R. equi* [@pone.0062879-Breathnach1]--[@pone.0062879-Liu1]. Thus, the relatively diminished immune responses of newborn foals may predispose them to infection with *R. equi* during early life.

The specific element(s) of immunity that predispose foals to infection with *R. equi* remain ill-defined. The purposes of the study reported here were: 1) to compare gene expression by foal peripheral blood leukocytes stimulated with virulent *R. equi* with gene expression of unstimulated leukocytes, at specific ages during the first 8 weeks of life (i.e., to compare gene expression of stimulated and unstimulated leukocytes within a specific age category); and 2) to compare genes differentially expressed following stimulation of foal leukocytes with *R. equi* during the first 8 weeks of life relative to those differentially expressed following stimulation at birth (i.e., to identify age-related changes in gene expression in response to *R. equi*). Our objective was to identify genes and their related pathways that might contribute to the age-related susceptibility to *R. equi* infection.

Materials and Methods {#s2}
=====================

Sample Collection {#s2a}
-----------------

The protocol for this study was approved by the Texas A&M University Institutional Animal Care and Use Committee (Animal Use Protocol \#2006-229). Six healthy Quarter Horse foals born at the Texas A&M University Horse Center were used in this study. All study foals were deemed to be healthy on the basis of results within reference ranges for complete blood counts on day 1 of life and absence of clinical signs throughout the study period. All foals were tested for evidence of passive transfer of maternal immunoglobulins and were found to have serum immunoglobulin concentrations \>800 mg/dL using a commercially available immunoassay (SNAP\* Foal IgG Test Kit, IDEXX Laboratories, Portland, ME). Approximately 60 mL of blood were collected in 10-mL tubes containing ethylenediamonetetracetic acid (EDTA) via jugular venipuncture from each foal at day 1 (within first 24 h of birth) and at 2, 4, and 8 weeks of age. Blood was immediately processed in the laboratory following collection. The blood was divided into two 30-mL aliquots; each 30-mL aliquot was equally divided into a 6-well tissue culture plate (i.e., 5 mL per well). For 1 aliquot (plate), live, virulent *R.equi* (strain ATCC 33701) suspended in 1 mL of phosphate-buffered saline (PBS) were added to each well at an approximate multiplicity of infection (MOI) of 10, while the other aliquot (plate) had an equivalent volume of PBS added and served as the unstimulated control. The number of bacteria needed to achieve the MOI was based on blood leukocyte concentration as determined using a cell counter (Cellometer Auto T4, Nexcelcom Bioscience, Lawrence, MA). The tissue culture plates were incubated for 2 h at 37°C in 5% CO~2~ with slow rotation. After incubation, blood for each aliquot (*R. equi*-stimulated or unstimulated) was combined, and the leukocytes were isolated and stabilized using a commercial kit (LeukoLOCK Total RNA Isolation System, Ambion, CA), according to the manufacturer's recommendations.

RNA Extraction and Amplification {#s2b}
--------------------------------

From the isolated and stabilized leukocytes, total RNA was extracted using the LeukoLOCK Total RNA Isolation System (Ambion, CA) according to the manufacturer's instructions. A DNase I treatment also was performed as a part of the RNA extraction protocol to remove any contaminating genomic DNA. Extracted RNA was quantified with a spectrophotometer (NanoDrop, Thermo Scientific, Wilmington, DE) and the RNA quality was subsequently assessed using a Bioanalyzer (Agilent 2100, Santa Clara, CA).

Due to low quantity of RNA obtained from some of the samples, RNA from all samples was amplified to ensure uniformity in processing samples. A total of 500 ng of RNA was included in each amplification reaction using a commercial kit (RampUP, Genisphere, Hatfield, PA), according to the manufacturer's protocol.

Labeling and Microarray Hybridization {#s2c}
-------------------------------------

For each sample, cDNA was generated from total RNA using Superscript II Reverse Transcription kit (Invitrogen, Carlsbad, CA) and labeled with Cy3 or Cy5 dye via an indirect labeling method utilizing dendrimer technology [@pone.0062879-Stears1]. Labeling was carried out with the 3DNA Array 900 MPX Expression Array Detection kit (Genisphere, Hatfield, PA).

Hybridizations were performed with 6 biological replicates at each experimental time-point: day 1 (D-1) and weeks 2 (W-2), 4 (W-4), and 8 (W-8). In order to compare the stimulated blood leukocytes with the unstimulated ones, we performed direct co-hybridization of cDNA from unstimulated samples and the corresponding stimulated samples at each experimental time-point ([Figure 1a](#pone-0062879-g001){ref-type="fig"}). Dye-swap was embedded in the biological replicates at each time point such that if the 3 samples of stimulated leukocytes were labeled with Cy3 and hybridized to 3 samples of unstimulated leukocytes labeled with Cy5; the opposite was done with the other 3 stimulated samples and unstimulated samples. Additionally, in order to obtain the temporal expression changes in the *in vitro R. equi* stimulated leukocytes, we utilized the common reference design for microarray hybridizations [@pone.0062879-Dobbin1]. The D-1 sample served as the reference for each foal and all other experimental samples from that foal were co-hybridized to it ([Figure 1b](#pone-0062879-g001){ref-type="fig"}). Hybridizations were performed in a SureHyb hybridization chamber (Agilent, Santa Clara, CA) at 55°C. Following post-hybridization washes, arrays were scanned with a GenePix 4000B scanner at 5-micron resolution (Molecular Devices, Sunnyvale, CA). GenePix Pro 6.1 software was utilized for raw data acquisition, spot-finding, and quantification of array images.

![Sample hybridization scheme for microarrays.\
**a.** Pairwise hybridization of stimulated (with live, virulent *R. equi*) and unstimulated samples was done at each time-point; **b.** Common reference design to hybridize samples from W-2, W-4, and W-8, with D-1 acting as the reference.](pone.0062879.g001){#pone-0062879-g001}

Equine 21K Oligonucleotide Microarray {#s2d}
-------------------------------------

An equine whole genome oligonucleotide array with 21,351 elements developed at Texas A&M University was used for gene expression analysis [@pone.0062879-Bright1]. This 70-mer oligoarray is one of the most comprehensive arrays available for equine research. The array elements map to various accessions, including those from the UniGene, UniProtKB, Entrez Gene and Non-Redundant Protein Databases. Probes were synthesized (Invitrogen, Carlsbad, CA) and printed onto amino-silane-coated slides (Corning Incorporated, Corning, NY). The equine oligoarray data are compliant with MIAME standards and the array data have been submitted to the NCBI Gene Expression Omnibus (GEO) database (accession number GSE45004).

Expression Analysis {#s2e}
-------------------

Differential expression analysis of microarray data was conducted using Bioconductor's LIMMA package running in the R statistical software environment [@pone.0062879-Smyth1]. Background correction of raw intensities was performed using the normexp correction method with offset 50 [@pone.0062879-Smyth2]. Subsequently, the background corrected intensities were normalized using printip-loess normalization (within array normalization) and aquantile normalization was used for across array normalization was performed [@pone.0062879-Smyth3]. To account for the multiple comparisons, the false discovery rate correction method of Benjamini and Hochberg was used [@pone.0062879-Benjamini1]. Linear models [@pone.0062879-Smyth1] were used to identify differentially expressed (DE) genes in the stimulated leukocytes (temporal expression) for the 3 comparisons of interest: a) day 1 versus week 2 (C1); b) day 1 versus week 4 (C2); and, c) day 1 versus week 8 (C3). Similarly, linear models were fit to obtain DE genes between the stimulated and the unstimulated leukocytes at each time-point (D-1, W-2, W-4, W-8). Genes were considered significantly differentially expressed if they had an adjusted p-value \<0.05 and fold-change \>1.5.

Functional Analysis {#s2f}
-------------------

Functional gene ontology analysis was performed using the web-based tool known as DAVID (The **D**atabase for **A**nnotation, **V**isualization and **I**ntegrated **D**iscovery version 6.7; accessible at <http://david.abcc.ncifcrf.gov/>) [@pone.0062879-Zhang1], [@pone.0062879-Duncan1]. Gene ontology analysis was performed using the list of differentially expressed genes to obtain statistically significant biological processes. In order to calculate the statistical significance, DE genes for each comparison were compared to all the genes present on our equine microarray. Statistical significance cutoff of 0.05 was considered and Benjamini-Hochberg method was used for multiple test adjustment.

Quantitative Real-Time PCR {#s2g}
--------------------------

To demonstrate the validity of gene expression results obtained by microarray, quantitative real-time PCR (RT-PCR) was performed on 4 genes selected for their biological importance and that were significantly differentially expressed (fold-change \>1.5 and p-value\<0.05) in our microarray results. Each gene was tested in duplicate along with a housekeeping gene control, beta actin (*ACTB*). Total RNA was directly reverse transcribed to cDNA using the SuperScript® VILO™ cDNA Synthesis Kit (Invitrogen, Carlsbad, CA) and subsequently amplified using gene-specific primers and master mix by RT-PCR in a single-step reaction. Serial dilutions of RNA from the reference sample were used to generate relative standard curves and test the amplification efficiency of each primer set. For each qPCR assay, ∼100 ng of total RNA were used in a 25-µl reaction with 1x Universal SYBR® Green Master Mix (Applied Biosystems, Carlsbad, CA) and 300 nM primers and amplified on a LightCycler 480 (Roche Diagnostics, Indianapolis, IN). The primer sets used to amplify the genes were designed using Primer3 software (<http://frodo.wi.mit.edu/primer3/>) and are listed in **[Table S1](#pone.0062879.s003){ref-type="supplementary-material"} in File S1**.

To validate the results obtained via microarray analysis, the expression levels of 4 selected genes were determined using RT-PCR: tumor necrosis factor (TNF), receptor-associated factor 3 *(TRAF3*), interleukin 1 beta *(IL1B),* interferon gamma *(IFN-γ)*, and nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha *(NFKBIA)*. The fold-changes in treated sample with respect to control were calculated using Pfaffl also known as delta-delta Ct method [@pone.0062879-Pfaffl1]. A Mann-Whitney U test was used to test the statistical significance of mRNA induction values and the test was performed using the online program available at <http://elegans.som.vcu.edu/~leon/stats/utest.html>.

Results {#s3}
=======

Number of Differentially Expressed Genes {#s3a}
----------------------------------------

Comparison of the stimulated versus unstimulated peripheral blood leukocytes at D-1 showed that 125 genes were differentially expressed, of which 89 were up-regulated and 36 down-regulated ([**Table 1**](#pone-0062879-t001){ref-type="table"} **, D-1**). A similar comparison for W-2 led to the identification of 127 DE genes, with 92 up-regulated and 35 down-regulated genes ([Table 1](#pone-0062879-t001){ref-type="table"}, W-2). At W-4, 73 genes were differentially expressed with 35 up-regulated and 38 down-regulated genes ([**Table 1**](#pone-0062879-t001){ref-type="table"} **, W-4**). Finally, at W-8 there were 135 genes that were differentially expressed, of which 92 were up-regulated and 43 down-regulated ([**Table 1**](#pone-0062879-t001){ref-type="table"} **, W-8**). A list of all DE genes is presented in [tables S5](#pone.0062879.s007){ref-type="supplementary-material"}--[S8](#pone.0062879.s010){ref-type="supplementary-material"}. The listed DE genes were common to all foals.

10.1371/journal.pone.0062879.t001

###### Differentially expressed (DE) genes.

![](pone.0062879.t001){#pone-0062879-t001-1}

  Comparison type                                   Time-point            DE genes       Total DE genes
  ------------------------------------------- ---------------------- ------------------ ----------------
  Stimulated versus unstimulated leukocytes         Day1 (D1)         Up: 89 Down: 36         125
                                                   Week-2 (W2)        Up: 92 Down: 35         127
                                                   Week-4 (W4)        Up: 35 Down: 38          73
                                                   Week-8 (W8)        Up: 92 Down: 43         135
  Temporal changes in stimulated leukocytes    Day1 vs. week-2 (C1)   Up: 30 Down: 72         102
                                               Day1 vs. week-4 (C2)   Up: 83 Down: 109        192
                                               Day1 vs. week8 (C3)    Up: 75 Down: 73         148

List of differentially expressed genes for each comparison is shown in the table. Genes were considered differentially expressed with P value\<0.05 and fold-change \>1.5. C1: comparison 1, C2: comparison 2, C3: comparison 3.

Likewise, when D-1 was compared to each of the remaining 3 time-points (W-2, W-4, and W-8) for the stimulated peripheral blood leukocytes, differentially expressed genes were identified for each indicating temporal changes in the gene expression profile. There were 102 DE genes for comparison C1 (D-1 vs. W-2), with the highest number of DE genes for comparison C2 (D1 vs. W-4; 192 genes), and finally C3 (D1 vs. W-8) with 148 DE genes. A list of all DE genes following *R. equi* stimulation is presented in the [Tables S9](#pone.0062879.s011){ref-type="supplementary-material"}--[S11](#pone.0062879.s013){ref-type="supplementary-material"}. The listed DE genes were common to all foals.

To validate the results obtained via microarray analysis, the expression levels of 4 selected genes were validated using RT-PCR: *TRAF3*, *IL1B, IFN-γ*, an*d NFKBIA*. The up-regulation of all 4 genes was confirmed at D-1 ([**Figure 2**](#pone-0062879-g002){ref-type="fig"}). Compared to unstimulated cells, increased expression of *IFN-γ* was found in stimulated cells at D-1 and W-8. In the stimulated leukocytes, *IFN-γ* mRNA expression was induced more at W-8 than D-1, and this increase was found to be statistically significant with P\<0.05 ([**Figure 2**](#pone-0062879-g002){ref-type="fig"}).

![Real-time PCR validation of microarray results.\
The y-axis represents the fold-change of the selected genes for validation using real-time PCR (white bars) and microarray (black bars). The Y-axis represents fold-change of selected genes by real-time PCR (delta-delta Ct method) and by microarray (normalized log2 (Cy5/Cy3)). \* represents significant (P\<0.05) difference in fold-change of IFN-γ at W-8 compared to D-1. IFN-γ has no corresponding black bar representing microarray data, as this gene was not printed on the microarray. The error bars indicate standard error of the mean (SEM) which was calculated as SEM = SD/√n, where SD represents standard deviation and n is the sample size.](pone.0062879.g002){#pone-0062879-g002}

Functional Analysis {#s3b}
-------------------

### Stimulated versus unstimulated blood leukocytes {#s3b1}

We performed functional analysis on the differentially expressed genes associated with each time-point. It appeared from our results that bacterial stimulation of leukocytes induced expression of various immune-related genes. The *in vitro R. equi* stimulation led to modulation of genes involved in cytokine and chemokine signaling, host innate immunity and defense, apoptosis, macrophage-mediated immunity, and various other processes listed in [**Table 2**](#pone-0062879-t002){ref-type="table"}.

10.1371/journal.pone.0062879.t002

###### Functional analyses of differentially expressed genes.

![](pone.0062879.t002){#pone-0062879-t002-2}

                                                                                                                         Day-1                                                                                                  Week-2                                                        Week-4                                                                                    Week-8
  ----------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------- ---------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------
  **Cytokine and chemokine mediated signaling** **pathway**                                              CCL20, IFNA5, IL1RN, IL1B,IL1A, TRAF3                                                                     CXCL3, IL1RN, IL1B, IL1A, CXCL10                                  CXCL2, IL1RN, IL1B,IL1A                                                        CCL20, IFNA5, CXCL2, IL1RN, IL1B, IL1A, CXCL10
  **Ligand-mediated signaling**                                                                     CCL20, INS-IGF2, IFNA5, EDN2, IL1RN, IL1B, IL1A                                                             CXCL3, EDN2, IL1RN, IL1B, IL1A, CXCL10                        EDN2, CXCL2, LILRB4, IL1RN, IL1B, IL1A                                        CCL20, INS-IGF2, IFNA5, EDN2, CXCL2, IL1RN, IL1B, IL1A, CXCL10
  **Apoptosis**                                                                                     DDX58, HIP1R, IFNA5, NFKBIA, IL1B, BIRC3, TRAF3                                                                DDX58, CUL3, NFKBIA, IL1B, BIRC3                                                                                                                     DDX58, CUL3, IFNA5, NFKBIA, IL1B, BIRC3
  **Immunity and defense**                                                             KLRB1, CCL20, IFNA5, IL1RN, NFKBIA, IL1B, TFCP2, HAGHL, UBP1, PTAFR, IL1A                                   CXCL3, IL1RN, NFKBIA, IL1B,TFCP2, UBP1, PTAFR, IL1A,SOD2, CXCL10           CXCL2, IL1RN, IL1B, TFCP2, PLAU, IL1A                       KLRB1, CXCL2, IL1RN, NFKBIA, TFCP2, UBP1, SOD2, CXCL10, CCL20, IFNA5, IL1B, IL1A, PTAFR, PLAU, GBP1
  **NF-kappaB cascade**                                                                          IL1RN, IL1B, IL1A, IFNA5,NFKBIA, TRAF3, BIRC3, TNFAIP3                                                                IL1RN, IL1B, IL1A, BIRC3                                      IL1RN, IL1B, IL1A,BIRC3                                                     IL1RN, IL1B, IL1A, IFNA5, CXCL2, NFKBIA, TRAF6, BIRC3
  **Macrophage-mediated immunity**                                                                                 IFNA5, IL1B, IL1A                                                                                   CXCL3, IL1B, IL1A, CXCL10                                        CXCL2, IL1B, IL1A                                                               IFNA5, CXCL2, IL1B, IL1A, GBP1, CXCL10
  **Cell surface receptor mediated signal transduction**              GNAI3, INS-IGF2, EDN2, IL1RN, GPR109A, RASGEF1B, OXTR, RALGDS, CCL20, IFNA5, IL1B, GNB3, IL1A, PTAFR, TRAF3           CXCL3, EDN2, OR13D1, IL1RN,RASGEF1B, IL1B, TPR, GRB7,GPR31, PTAFR, IL1A, CXCL10   OR1A1, EDN2, CXCL2, IL1RN, IL1B, IL1A              GPR84, INS-IGF2, EDN2, GPR109A, CXCL2, NPBWR2, IL1RN, RASGEF1B, CXCL10, CCL20, IFNA5, IL1B, IL1A, PTAFR, RHOG, GPR31
  **G-protein mediated signaling**                                                                  GNAI3, EDN2, GPR109A, OXTR, GNB3, RALGDS, PTAFR                                                                                                                                                                                                                GPR84, EDN2, GPR109A, NPBWR2, GPR31, RHOG, PTAFR
  **Signal transduction**                                      GNAI3, INS-IGF2, EDN2, IL1RN, GPR109A, RASGEF1B, NFKBIA, OXTR, RALGDS, CCL20, IFNA5, IL1B, GNB3, CLINT1, IL1A,PTAFR, TRAF3                                                                                                                              GPR84, INS-IGF2, EDN2, GPR109A, IL1RN, CXCL2, NPBWR2, RASGEF1B, NFKBIA, CXCL10, CCL20, IFNA5, RSPH3, IL1B, PLAU, IL1A, PTAFR, RHOG, GPR31
  **Cell proliferation and differentiation**                                                                                                                                                               CABP2, CXCL3, STAMBPL1,NFKBIA, IL1B, IL1A, CXCL10                                                          
  **Cell structure and motility**                                                                                                                                                                                                                                                                                                                               VAPB, CXCL2, NPBWR2, KIF21A, RHOG, PLAU, PTAFR, CXCL10
  **Intracellular protein traffic**                                                                                                                                                                                                                                                                                                                                LMBR1L, OLR1, VAPB, RSPH3, NFKBIA, KIF21A, SNX10
  **Interferon-mediated Immunity**                                                                                                                                                                                                                                                                                                                                                IFNA5, GBP1, CXCL10

Biological processes associated with differentially expressed genes when *R. equi*-stimulated leukocyte expression was compared to unstimulated leukocytes at day 1 and week 2, 4, and 8.

The genes up-regulated in the stimulated leukocytes (compared within age to unstimulated) appeared to be various up-and down-stream components of Toll-like receptor (TLR) signaling (**[Figure S1i](#pone.0062879.s001){ref-type="supplementary-material"}n File S1**) and the NF-κB activation cascade (**[Figure S2](#pone.0062879.s002){ref-type="supplementary-material"} in File S1**). Soon after birth (D-1), we observed modulation of genes involved in nuclear factor-kappaB (NF-κB) signaling in response to ligation of TLRs or interleukin-1 receptor (IL-1R) (**[Figure S1](#pone.0062879.s001){ref-type="supplementary-material"} and [S2](#pone.0062879.s002){ref-type="supplementary-material"} in File S1**). Several genes at each time-point were present at the various stages of the NF-κB pathway: a) genes that belong to ligands and receptors, viz., *IL1A, IL1B, IL1RN* (D-1, W-2, W-4, W-8); and b) downstream signaling, viz., *TNFAIP3 (A20), TRAF3* (D-1), *TRAF6* (W-8), *NFKIBIA* (D-1, W-2, W-8), and *BIRC3* (D-1, W-2, W-4, W-8).

A variety of chemokines was induced across the time-points in stimulated cells compared to unstimulated: chemokine (C-C motif) ligand 20 (*CCL20)* at D-1; chemokine (C-X-C) motif ligand 3 (*CXCL3)* and *CXCL10* at W-2; *CXCL2* at W-4; and *CCL20*, *CXCL2*, and *CXCL10* at W-8. The biological processes associated with down-regulated gene expression by *R. equi* stimulation on D-1 were involved in wound healing and blood coagulation. On D-1, we observed down-regulation of genes involved in coagulation and platelet activation viz., signal peptide, CUB domain, EGF-like 1 (*SCUBE1)*, selectin P (*SELP)*, and phospholipid scramblase 1 (*PLSCR1*); however, at older ages (W-2 and W-4) there was evidence of up-regulation of genes associated with coagulation and platelet activation viz., plekstrin (*PLEK)* and platelet-activating factor receptor (*PTAFR)* at W-2, and plasminogen activator, urokinase *PLEK* and plasminogen activator, urokinase (*PLAU)* at W-4. Genes like L-plastin (*LCP1*) and L-selectin (*SELP*) that are involved in host immunity against pathogens were also found to be down-regulated at D-1.

The results suggest that stimulation with *R. equi* leads to activation of elements involved in pro-inflammatory pathways. However, it also appears that young foals at D-1 have a reduced repertoire of chemokines and lowered expression of some genes involved in responding to pathogens (e.g., *SELP*).

In order to identify the genes that were unique for each experimental time-point, we compared the list of DE genes across all 4 time-points and obtained the intersection and union of the gene sets ([**Figure 3**](#pone-0062879-g003){ref-type="fig"}). The expression profile at each time-point appeared to be largely distinct with very few common genes as depicted in [**Figure 3**](#pone-0062879-g003){ref-type="fig"}. Out of the 88 (D-1), 88 (W-2), 51 (W-4), and 87 (W-8) genes differentially expressed at each time-point, only 11 genes were identified at all 4 times indicating that the expression profile was largely unique for each of the 4 time-points. This small fraction of genes commonly induced by *R. equi* stimulation among the various ages (time-points) was consistent with our findings of age-related differences in the expression profile of neonatal immune cells described in the ensuing section.

![Venn diagram for pairwise comparison of the gene expression profile of stimulated versus unstimulated leukocytes.\
The 4 time-points are designated in the diagram as 1: day 1, 2: week 2, 3: week 4, 4: week 8. The letters represent: a-genes found in 1 only; b-genes found in 2 only; c-genes found in 3 only; d-genes found in 4 only; e-genes in 1&2 only; f-genes in 1&3 only; g-genes in 2&3 only; h-genes in 1&4 only; i-genes in 2&4 only; j-genes in 3&4 only; k-genes in 1,2,3 only; l-genes in 1,2,4 only; m-genes in 1,3,4 only; n-genes in 2,3,4 only; and, o-genes in 1,2,3, and4. \*Only genes with an annotated accession were used for generating this figure.](pone.0062879.g003){#pone-0062879-g003}

### Temporal changes in stimulated blood leukocytes {#s3b2}

We also performed functional analysis of the genes differentially expressed in response to stimulation at ages 2, 4, and 8 weeks relative to stimulated responses on D-1 (i.e., comparisons C1, C2, and C3). For comparison C1, the biological processes (GO terms) associated with the up-regulated genes were primarily those involved in antigen processing and presentation and host defense response, including MHC class II presentation associated with CD4+ T cell responses (**[Table S2a](#pone.0062879.s004){ref-type="supplementary-material"} in File S1**). For the C2 comparison, the up-regulated genes were associated with protein and ion transport (**[Table S3a](#pone.0062879.s005){ref-type="supplementary-material"} in File S1**). For the C3 comparison, the up-regulated genes were primarily associated with antigen processing (via MHC class II) and presentation and protein metabolism (**[Table S4a](#pone.0062879.s006){ref-type="supplementary-material"} in File S1**). Down-regulated genes for each of the comparisons (C1, C2, and C3) appeared primarily to involve lipid metabolism and transport.

We compared the list of DE genes obtained for each temporal comparison and found the groups of DE genes that were common for 2 or more of the comparisons. ([**Figure 4**](#pone-0062879-g004){ref-type="fig"}). The expression profiles of the 3 comparisons (C1, C2, and C3) were largely distinct, with the largest overlap between C1 and C2 (30 genes). None of the genes were present in all 3 comparisons, highlighting the uniqueness of the expression profile at each age.

![Venn diagram for temporal gene expression changes.\
This Venn diagram depcts DE genes unique to each comparison: day1-week2 (C1); day1-week4 (C2); and, day1-week8 (C3). \*Only genes with an annotated accession were used for generating this figure.](pone.0062879.g004){#pone-0062879-g004}

Discussion {#s4}
==========

The gene expression profile of the stimulated leukocytes compared to the unstimulated ones appeared to be largely unique for each time-point. Across time-points, stimulation with *R. equi* induced genes in leukocytes that were involved in defense mechanisms such as inflammation. More importantly, we observed age-related differences in expression of genes involved in host immune responses highlighting diminished immunity during early life of foals. We found induction of genes critical for host immunity against intracellular pathogens such as *R. equi* (viz., MHC class II) only at the later time-points (relative to the day of birth) [@pone.0062879-Flaminio1], [@pone.0062879-Jacks1]. Moreover, compared to the unstimulated cells, at birth the stimulated leukocytes displayed reduced expression of genes involved in the various components of innate and adaptive immunity (e.g., down-regulation of genes associated with host immune response such as IFN-γ production at D-1). Therefore, results of this study suggest age-dependent differences in immunity as a plausible underlying factor contributing to susceptibility of foals to *R. equi*.

Stimulated Responses of Blood Leukocytes at Each Age-Point {#s4a}
----------------------------------------------------------

When the expression profiles of the stimulated leukocytes were compared to the unstimulated ones within age, a pattern emerged across all 4 time-points. The central theme that surfaced was that bacterial stimulation led to induction of molecular mechanisms involved in the activation of innate immune responses and inflammation via activation of components of the NF-κB cascade (**[Figure S2](#pone.0062879.s002){ref-type="supplementary-material"},** [**Table 2**](#pone-0062879-t002){ref-type="table"}).

NF-κB is a critical regulator of host innate immune response and activates inflammatory and cell-survival pathways [@pone.0062879-Ashida1]. Our results suggest that *in vitro R. equi* stimulation possibly leads to activation of NF-κB via TLR signaling or induction by IL-1α (the gene product of *IL1A*)/IL-1β (the gene product of *IL1B*) ligand interaction with IL-1 receptor to initiate inflammatory pathways. Activation of NF-κB leads to secretion of pro-inflammatory cytokines like interleukin IL-1α and IL-1β. The products of *IL1A* and *IL1B* are pyrogens and capable of inducing fever [@pone.0062879-Hartung1]. Fever is a non-specific host response to elevate the body temperature that may help protect against infections with bacteria, including *R. equi*. The products of the *IL1A* and *IL1B* genes are also involved in innate responses including up-regulation of endothelial adhesins for neutrophils, induction of acute-phase proteins, and early recruitment of inflammatory cells to the sites of infection [@pone.0062879-Burger1]. These innate responses may further help protect foals against infection against *R. equi* in a non-specific manner. Innate immune responses play a direct protective role against *R. equi* infections in mice [@pone.0062879-Martens1] and also likely serve as an important bridge to protective adaptive immune responses [@pone.0062879-Darrah1].

Modulation of genes involved in TLR signaling that leads to activation of NF-κB was observed ([**Figure 2**](#pone-0062879-g002){ref-type="fig"}). Activation of TLR2 and TLR9 and downstream signaling are considered to be involved in response to *R. equi* infection [@pone.0062879-Darrah1], [@pone.0062879-Liu1]. TLR9 senses unmethylated CpG DNA of viruses and bacteria, and induces interferon IFN-α expression from plasmacytoid dendritic cells (pDC's) [@pone.0062879-Perry1]. Consistent with TLR9 activation, we suggest that *R. equi* stimulation activated TLR9 signaling via up-regulation of *TRAF3* expression leading to an increased expression of *IFNA5*; however, we lack translational (protein-level) evidence to corroborate our gene expression data.

Chemokines are a subset of cytokines capable of chemoattraction of immune cells. A variety of chemokine genes were induced across the time-points: *CCL20* on D-1; *CXCL3* and *CXCL10* at W-2; *CXCL2* at W-4; and, *CCL20*, *CXCL2*, and *CXCL10* at W-8. CCL20 is important during the initiation of an immune response [@pone.0062879-Ashida1] and is involved in chemotaxis of immature dendritic cells and effector T- and B-lymphocytes [@pone.0062879-Schutyser1]. *CXCL2* is important for neutrophil recruitment, and neutrophils are important for protection against infection with *R. equi* [@pone.0062879-Martens1]. Induction of *CXCL10* is involved in activation and recruitment of CD4+ and CD8+ T-cells [@pone.0062879-Lande1]. CD4+ T-cells are critical in effective clearance of *R. equi* [@pone.0062879-Kanaly1], making induction of *CXCL10* a key factor in host immune response.

CXCL2 appears to be involved as an activating component of innate immunity while CXCL10 is predominantly involved in inducing adaptive immunity via T-lymphocyte recruitment. The variation in chemokine profiles among time-points reveals that fewer chemokine genes are induced in foals close to birth, and as they age (by week 8), a wider spectrum of chemokines having critical roles in immune responses to infection are induced in response to stimulation with *R. equi*.

The chemokine CXCL10 is involved in activation of effector T-cells critical for *R. equi* clearance and was induced at later time-points but not at D-1. The expression of this chemokine is induced by IFN-γ [@pone.0062879-Hardaker1]. Evidence exists that foals are deficient in producing IFN-γ at birth and that its levels increase as foals age [@pone.0062879-Breathnach1], [@pone.0062879-Boyd1]. Thus, it is possible that the induction of *CXCL10* and another interferon-inducible gene such as guanylate binding protein 2 *(GBP2)* at W-8 was driven by increased INF-γ expression. Although the gene for INF-γ was not included on our microarray, we were able to demonstrate using RT-PCR that there was significantly increased expression of *IFN-γ* at W-8 compared to D-1; this finding supports the possibility of *CXCL10* and *GBP2* expression having been influenced by *IFN-γ* expression, and substantiates previous reports regarding age-related differences of increased expression of *IFN-γ* as neonatal foals age [@pone.0062879-Breathnach1], [@pone.0062879-Boyd1]. Interestingly, *GBP2* belongs to the GTPase gene family which has a putative role in resistance to intracellular pathogens [@pone.0062879-MacMicking1].

Down-regulation of various other genes possibly points toward diminished immunity of foals at birth. Alternatively, repression of these immune-related genes may suggest microbial attenuation of host immune response at younger ages. For example, down-regulation of L-plastin (*LCP1*) and L-selectin (*SELP*) was observed at D-1. L-plastin has a role in T-cell activation due to its role in the actin cytoskeleton re-arrangement that is critical for TCR signaling. Loss of function of L-plastin in neutrophils leads to defects in activation of respiratory burst, and down-regulation of this gene impairs T-cell responses to antigen manifested by reduced production of IFN-γ and IL-17 [@pone.0062879-Wang1]. Our results indicate reduced expression of the *SELP* gene in stimulated leukocytes on D-1. Inhibition of *SELP* expression during *R. equi* infection has been suggested to decrease the maturation and responsiveness of dendritic cells, thereby dampening the host response to this pathogen [@pone.0062879-Heller1]. Thus, *SELP* down-regulation at D-1 could suggest either a deficiency of the host response to *R. equi* or modulation of host immunity by the pathogen. Similarly, at D-1 we observed down-regulation of various genes involved in coagulation and platelet activation (viz., *SCUBE1, SELP, and PLSCR1*), whereas at older ages (W-2 and W-4) there was evidence of up-regulation of genes associated with coagulation and platelet activation (viz., *PLEK and PTAFR* at W-2 and *PLEK and PLAU* at W-4). Platelet activation may have relevance to *R. equi* infections in foals. Thrombocytosis occurs in association with infections, including foal pneumonia [@pone.0062879-Sellon1]. Moreover, in mycobacterial infection of lungs, platelets may have a protective role wherein the aggregation of platelets results in obstruction of blood vessels around the foci of infection that prevents the spread of bacteria [@pone.0062879-Buyukasik1].

We identified that *R. equi* exposure of immune cells leads to activation of various components of TLR and NF-κB cascade. Inability of a foal to activate such inflammatory responses early in life may increase their susceptibility to *R. equi* infection. We also identified genes that appear to be associated with age-related differences in immune response. Genes down-regulated at birth such as *IFN-γ*, *CXCL10* and other chemokines, *SELP* and *LCP1* could result in increased susceptibility to *R. equi* infection. Novel drugs and vaccines administered early in life can thus be designed and evaluated for their ability to enhance protective immune responses associated with these genes in young foals.

Temporal Changes in Gene Expression {#s4b}
-----------------------------------

Very few genes induced by *R. equi* stimulation were common among ages ([**Figure 4**](#pone-0062879-g004){ref-type="fig"}), suggesting that the expression profile at each time-point was distinct. Nevertheless, compared to a 1-day-old foal with naïve immunity, changes in the expression profile over the ensuing 8 weeks demonstrated a theme of immune development, as manifested by up-regulation of a variety of immune-related genes at later time-points. Collectively, these findings suggested that immune function was diminished on D-1 relative to older ages.

Compared to the changes in expression profile of stimulated leukocytes at D-1, various genes involved in immune response and inflammation were up-regulated at later time-points, such as MHC class-II genes (*HLA-DRA*, *HLA-DQB1*) and indoleamine 2,3 dioxygenase (*INDO*). Up-regulation of MHC class II genes at W-2 and older is consistent with the observed increase in MHC class II lymphocytes with age during the first month of life of foals [@pone.0062879-Smith1]. At birth, reduced MHC II class antigen presentation can reduce activation of class II-restricted CD4+ T-cells [@pone.0062879-Gercken1], and evidence exists that CD4+ cells are critical in clearance of *R. equi* infection in mice and horses [@pone.0062879-Kanaly1], [@pone.0062879-Heller1]. Thus, a reduced expression of MHC class II genes in foals at birth could contribute to increased disease susceptibility. Relative to D-1, *INDO* expression was also up-regulated at W-2, W-4, and W-8 in stimulated leukocytes. The *INDO* gene has been reported to have a role in defense against intracellular pathogens due to the ability of the encoded enzyme to restrict pathogen growth either by depletion of tryptophan or by dampening inflammatory responses [@pone.0062879-Heller2].

There are various studies that support a critical role of IFN-γ in the clearance of *R. equi*. Unfortunately, the IFN-γ gene was not represented on our microarray and therefore we have no direct evidence supporting the age-dependent induction [@pone.0062879-Breathnach1], [@pone.0062879-Boyd1]. However, as indirect evidence we did observe down-regulation of *CCL20* across later time-points relative to D-1. It has recently been proposed that chemokine CCL20 has a role early in infection after which its levels are down-regulated by induction of IFN-γ [@pone.0062879-RiveroLezcano1]. Furthermore, MHC class-II genes which are interferon-inducible, were up-regulated only at later time-points compared to their expression at birth. Our RT-PCR data support this observation, since we found mRNA levels of *IFN-γ* to be significantly higher at W-8 than D-1.

Age-related modulation towards lowered expression of genes involved in lipid transport and metabolism was observed for all 3 stimulated response comparisons (C1, C2, and C3). Lipid metabolism is a major source of energy for mycobacteria and, if a similar mechanism exists in *R. equi*, then down-regulation of lipid transport and metabolism genes is perhaps modulated to reduce survival of the pathogen.

This study is one of the first to use a whole genome expression array to understand foal immune responses to *R. equi*. However, we would also like to address some of the limitations of this study. One of the shortcomings of this study was that the mRNA for the expression analysis was obtained after only a single time-period (viz., 2 h) of *in vitro* incubation of peripheral blood leukocytes with *R. equi*. Previous studies from our laboratory have indicated that significant mRNA expression of key immune-related cytokines (e.g., IFN-γ, IL-6, and IL12p40) was obtained by stimulating foal peripheral blood mononuclear cells and neutrophils with *R. equi* for 2 h [@pone.0062879-Liu1], [@pone.0062879-Bordin1]. Unpublished data from this study also suggested that mRNA expression of various cytokines using this short incubation period was not significantly lower than longer incubations (4, 8, 12, or 24 h). While our unpublished results revealed that longer stimulation times generally yielded higher expression of some cytokines, it also affected the quality and quantity of RNA extracted. Therefore, we elected to use a 2 h incubation period for this study.

Another limitation of this study is that the experimental design makes it difficult to dissect the effects of maturation in response to natural exposure from deficiency. Although *in vitro* stimulation of blood leukocytes from healthy foals was performed, the foals would have been exposed to environmental *R. equi* isolates; thus, the age-related differences in expression profile we observed could simply reflect the transition of young foals from a naïve, unexposed state to an exposed state. *Rhodococcus equi* is widespread in the environment of foals [@pone.0062879-Cohen1]--[@pone.0062879-Muscatello2], making it challenging to control exposure to the pathogen without creating other possible sources of bias. Finally, we acknowledge that whole blood leukocytes were used for the purpose of this study. Thus, it is possible that differences in expression profiles were related to differences in subpopulations of leukocytes. Although this limitation would not have affected our within-age comparisons (where the distribution of cell subpopulations would have been the same for individual foals), it is relevant to our between age comparisons. We note, however, that our total leukocyte counts across age showed no significant differences among ages, and the ratio of neutrophils to lymphocytes was never less than 1.3 (unpublished data, not included in the manuscript). A tenable case can be made that the gene expression profile of those leukocytes in circulation at a given age better reflect the expected composite host response to infection than those of isolated subpopulations. Indeed, this was our rationale for examining total leukocytes in this study.

Conclusions {#s4c}
-----------

We characterized the age-related gene expression profile of neonatal foals during the first 8 weeks of life associated with stimulation of peripheral blood leukocytes by *R. equi*. We also identified genes that were modulated temporally when blood leukocytes were stimulated with virulent *R. equi*. In this study we report the induction of innate immune response genes by stimulation of neonatal foal leukocytes with *R. equi*. Induction of such genes is likely critical in defense against *R. equi*, and lowered expression/repression of such genes in certain foals could render them highly susceptible to develop *R. equi* pneumonia once exposed to the pathogen. While it appears that foals of up to 8 weeks of age are able to initiate a protective defense and inflammatory response against the bacteria, relatively decreased expression or repression of various other immune-related genes points toward diminished immune responses closer to birth. The relatively reduced/repressed expression of such genes could also reflect immune-modulation of host responses by the pathogen for its survival. If foals generally become infected early in life, as supported by some research findings [@pone.0062879-Chaffin1], [@pone.0062879-Horowitz1], the genes and associated pathways identified by this study could be targeted for disease prevention or for developing novel therapeutic interventions. For example, enhanced MHC II/Th1-type immune responses might help protect foals against *R. equi* and other intracellular pathogens (e.g., *Salmonella*) during early life.
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**Toll-like receptor signaling pathways.** Red arrows indicate the genes involved in TLR2 and TLR9 signaling pathways differentially expressed in *R. equi*-stimulated leukocytes compared to unstimulated. Illustration reproduced, courtesy of Cell Signaling Technology, Inc. ([www.cellsignal.com](http://www.cellsignal.com)).
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**NF-kB activation cascade.** Red arrows indicate the genes involved in NF- **kB** activation that are differentially expressed in *R. equi*-stimulated leukocytes compared to unstimulated. Illustration reproduced, courtesy of Cell Signaling Technology, Inc. ([www.cellsignal.com](http://www.cellsignal.com)).

(TIF)

###### 

Click here for additional data file.

###### 

**List of primers for real-time PCR validation.**

(DOCX)

###### 

Click here for additional data file.

###### 

**Functional analysis of up-regulated genes in C1.**

(DOCX)

###### 

Click here for additional data file.

###### 

**Functional analysis of up-regulated genes for C2.**

(DOCX)

###### 

Click here for additional data file.

###### 

**Functional analysis of up-regulated genes in C3.**

(DOCX)

###### 

Click here for additional data file.

###### 

**List of differentially expressed genes (pvalue \<0.05 and fold-change cut off of 1.5) between the stimulated and the unstimulated leukocytes at Day 1.**

(DOCX)

###### 

Click here for additional data file.

###### 

**List of differentially expressed genes (pvalue \<0.05 and fold-change cut off of 1.5) between the stimulated and the unstimulated leukocytes at Week-2.**

(DOCX)

###### 

Click here for additional data file.

###### 

**List of differentially expressed genes (pvalue \<0.05 and fold-change cut off of 1.5) between the stimulated and the unstimulated leukocytes at Week-4.**

(DOCX)

###### 

Click here for additional data file.

###### 

**List of differentially expressed genes (pvalue \<0.05 and fold-change cut off of 1.5) between the stimulated and the unstimulated leukocytes at Week-8.**

(DOCX)

###### 

Click here for additional data file.

###### 

**List of differentially expressed genes (pvalue \<0.05 and fold-change cut off of 1.5) between the stimulated leukocytes at Week-2 compared to Day 1.**

(DOCX)

###### 

Click here for additional data file.

###### 

**List of differentially expressed genes (pvalue \<0.05 and fold-change cut off of 1.5) between the stimulated leukocytes at Week-4 compared to Day 1.**

(DOCX)

###### 

Click here for additional data file.

###### 

**List of differentially expressed genes (pvalue \<0.05 and fold-change cut off of 1.5) between the stimulated leukocytes at Week-8 compared to Day 1.**

(DOCX)

###### 

Click here for additional data file.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: Conceived and designed the experiments: NDC BPC AGS. Performed the experiments: PK AGS ML. Analyzed the data: PK II. Contributed reagents/materials/analysis tools: NDC BPC AGS. Wrote the paper: PK II NDC AGS ML BPC. Collected blood samples: NDC.
